E. I. du Pont de Nemours and Company (NYSE:DD) released that its third quarter earnings of $0.54 a share, excluding non-recurring items, $0.01 improved than the Capital IQ Consensus Estimate of $0.53; revenues increased 0.8 percent year/year to $7.87B as compared to the $7.94B consensus., reflecting portfolio changes, as price, volume and currency were in line with the prior year period. E. I. du Pont de Nemours and Company (NYSE:DD) begun last trade with a price of $68.57 and throughout the trading session climbed at a high of $68.90. The day-trade ended with 0.10% to $67.95. The stock is going forward to its 52 week low with 17.04% and lagging behind from its 52 week high price with -6.82%. DD last month stock price volatility remained 1.70%.United Therapeutics Corporation (NASDAQ:UTHR) released that its third quarter earnings of $3.91 per share, may not be similar to the Capital IQ Consensus anticipates of $1.73; revenues increased 9.2% year/year to $330M as compared to the $334.13M consensus. United Therapeutics Corporation (NASDAQ:UTHR) has the market capitalization of 6.168 Billion. Shares of firm moved down -2.00% to close at $130.49 with the total traded volume of 2.06 Million. The firm has current ratio of 1.30 for the most recent quarter.Radware Ltd. (NASDAQ:RDWR) released that its third quarter adjustment earnings of $0.24 a share, $0.05 improved than the Capital IQ Consensus anticipates of $0.19; revenues increased 18.3% year/year to $56.8M vs. the $54.68M consensus. Non-GAAP Operating Income at 20%. Radware Ltd. (NASDAQ:RDWR) stock price closed at $18.77 with the total traded volume of 1.12 Million shares. Its price to sales ratio ended at 4.06. Its market capitalization is 846.1 Million. The stock owned by the Financial Institutions was 72.10% while by insiders was 10.34%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
